2-185738791-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NR_110217.1(FSIP2-AS2):n.99+1588A>G variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000795 in 1,383,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000079 ( 0 hom. )
Consequence
FSIP2-AS2
NR_110217.1 intron, non_coding_transcript
NR_110217.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.579
Genes affected
FSIP2-AS2 (HGNC:54061): (FSIP2 antisense RNA 2)
FSIP2-AS1 (HGNC:40978): (FSIP2 antisense RNA 1)
FSIP2 (HGNC:21675): (fibrous sheath interacting protein 2) This gene encodes a protein associated with the sperm fibrous sheath. Genes encoding most of the fibrous-sheath associated proteins genes are transcribed only during the postmeiotic period of spermatogenesis. The protein encoded by this gene is specific to spermatogenic cells. Copy number variation in this gene may be associated with testicular germ cell tumors. Pseudogenes associated with this gene are reported on chromosomes 2 and X. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-185738791-T-C is Benign according to our data. Variant chr2-185738791-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 3097241.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | NR_110217.1 | n.99+1588A>G | intron_variant, non_coding_transcript_variant | |||||
FSIP2 | NM_173651.4 | upstream_gene_variant | ENST00000424728.6 | NP_775922.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | ENST00000427269.2 | n.101+1588A>G | intron_variant, non_coding_transcript_variant | 5 | ||||||
FSIP2-AS1 | ENST00000667756.1 | n.37+49975A>G | intron_variant, non_coding_transcript_variant | |||||||
FSIP2-AS2 | ENST00000437717.1 | n.119+116A>G | intron_variant, non_coding_transcript_variant | 3 | ||||||
FSIP2 | ENST00000424728.6 | upstream_gene_variant | 5 | NM_173651.4 | ENSP00000401306 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000759 AC: 1AN: 131674Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 71668
GnomAD3 exomes
AF:
AC:
1
AN:
131674
Hom.:
AF XY:
AC XY:
0
AN XY:
71668
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000795 AC: 11AN: 1383684Hom.: 0 Cov.: 31 AF XY: 0.0000103 AC XY: 7AN XY: 682804
GnomAD4 exome
AF:
AC:
11
AN:
1383684
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
682804
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at